Skip to Main Content

Paper Details

Efficacy and safety of pembrolizumab for patients with previously treated advanced vulvar squamous cell carcinoma: Results from the phase 2 KEYNOTE-158 study.
Gynecol Oncol
15
2022
Author NameAffiliation
Jose A Lopez-Martin12 de Octubre University Hospital & Research Institute (i+12)
  • 1 - 1

Datasets

Release 1.2